• KOL
    • Retinitis Pigmentosa
    • Thaddeus P Dryja
    • THADDEUS P Dryja: Influence Statistics

      THADDEUS P Dryja

      THADDEUS P Dryja

      Show email address

      Current affiliation: *TPD Cogan Eye Pathology Laboratory, Massachusetts Eye and Ear, Boston, Massachusetts, United States. | From the David G. Cogan Laboratory of Ophthalmic ...

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

      THADDEUS P Dryja:Expert Impact

      Concepts for whichTHADDEUS P Dryjahas direct influence:Retinitis pigmentosa,Rhodopsin gene,Retinoblastoma gene,Recessive mutations,Dominant retinitis pigmentosa,Macular degeneration,Retinoblastoma locus,Heterozygous carriers.

      THADDEUS P Dryja:KOL impact

      Concepts related to the work of other authors for whichfor which THADDEUS P Dryja has influence:Retinitis pigmentosa,Retinal degeneration,Gene expression,Photoreceptor cells,Cell cycle,Human pair,Retinoblastoma protein.

      KOL Resume for THADDEUS P Dryja

      Year
      2021

      Current affiliation: *TPD Cogan Eye Pathology Laboratory, Massachusetts Eye and Ear, Boston, Massachusetts, United States.

      From the David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.

      2019

      David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary/Harvard Medical School, Boston, MA, USA

      Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts

      2018

      David G. Cogan Ophthalmic Pathology Laboratory.

      Novartis Institutes for Biomedical Research, Cambridge, Massachusetts

      MIT Media Lab, 75 Amherst St, Cambridge, MA, USA

      2017

      Novartis Institutes for BioMedical Research, 02139, Cambridge, Massachusetts, USA

      2016

      Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston

      2015

      Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA.

      2014

      Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States.

      2010

      Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.

      The Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, USA

      2009

      Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA

      2008

      Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles Street, 02114, Boston, Massachusetts, USA

      Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA

      2007

      Department of Ophthalmology, Harvard Medical School, and Massachusetts Eye and Ear Infirmary, Boston (Drs DeAngelis, Kim, Miller, and Dryja and Mr Adams)

      Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye & Ear Infirmary, Boston, MA, USA

      2006

      Ocular Molecular Genetics Institute, Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts

      Departments of Ophthalmology (D.S.W., S.M., T.P.D.), Pediatrics (D.S.W., E.F.G.), and Radiation Oncology (J.E.M.), Harvard Medical School — all in Boston.

      2005

      Department of Ophthalmology and

      2004

      Ocular Molecular Genetics Institute and

      2003

      From the Department of Ophthalmology (E.J.D., M.N., I.K.G., A.S.T., T.P.D., J.C.A., C.H.D.), Harvard Medical School, Massachusetts Eye and Ear Infirmary, Schepens Eye Research Institute, Boston, Massachusetts, U.S.A.; Mayo Clinic (K.H.B.), Rochester, Minnesota, U.S.A.

      Human Molecular Genetics11, 1219–1227 (2002)

      2002

      Ocular Molecular Genetics Institute, Harvard Medical School and Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114 USA

      2001

      Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts

      2000

      Department of Ophthalmology, Harvard Medical School and the Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA

      Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA, U.S.A.

      1999

      Ocular Molecular Genetics Institute, Boston, Massachusetts, USA

      Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts

      1998

      Ocular Molecular Genetics Institute and Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles Street, 02114, Boston, Massachusetts, USA

      1997

      Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, U.S.A.

      Ocular Molecular Genetics Institute, Massachusetts Eye and Ear Infirmary, Boston

      1996

      Ocular Molecular Genetics Institute and Taylor Smith Laboratory, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles St., 02114-3096, Boston, Massachusetts, USA

      Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, 02114

      1995

      Howe Laboratory, Harvard Medical School and Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA

      1994

      Howe Laboratory of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.

      Harvard Medical School and Massachusetts Eye and Ear Infirmary, 243 Charles Street, 02114, Boston, MA, USA

      1993

      Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston 02114.

      Berman-Gund Laboratory for the Study of Retinal Degenerations and the Howe Laboratory of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles Street, 02114, Boston, Massachusetts, USA

      1992

      Boston, Massachusetts

      1991

      Harvard Medical School, Department of Ophthalmology, Boston, Massachusetts 02114 USA

      Howe Laboratory of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston

      Sign-in to see all concepts, it's free!
      Sample of concepts for which THADDEUS P Dryja is among the top experts in the world.
      Concept World rank
      larger visual fields #1
      arrp lrat #1
      rb1 carriers #1
      rgr 11cis retinal45 #1
      deletions single codons #1
      mutations encode proteins #1
      oguchi disease forms #1
      chromosome recessive alleles #1
      alleles fathers #1
      rp1 sca7 #1
      30 dark adaptation #1
      cells functional copies #1
      bmd 3 utr #1
      syndrome gfs #1
      rgr müller #1
      common identified 4 #1
      pigmentosa amino #1
      8q11–13 north america #1
      altered carboxy termini #1
      pro347leu pro347ser #1
      polymorphisms retinoblastoma #1
      t17 mutation #1
      arrestin cases #1
      rp clinical features #1
      genetically events #1
      japanese patients1 #1
      iris horner #1
      impdh1 form #1
      lps ocular #1
      eukaryotes123456 #1
      fd neutralizing #1
      pigmentosa alleles #1
      val345met disease #1
      electron dominant humans #1
      rds separate families #1
      rflp rb locus #1
      esd locus human #1
      patients nonhereditary disease #1
      rgs9 activity #1
      impdh1 gene patients #1
      lrat north america #1
      3 retinoblastomas #1
      small pieces capability #1
      tubby mice1–4 #1
      17 mutations disease #1
      paternally derived copy #1
      phe45leu #1
      swedish impdh1 #1
      complement mrna #1
      subunit rod phosphodiesterase #1
      Sign-in to see all concepts, it's free!

      Prominent publications by THADDEUS P Dryja

      KOL-Index: 16416

      We determined the mutation spectrum of the RP2 and RPGR genes in patients with X-linked retinitis pigmentosa (XLRP) and searched for correlations between categories of mutation and severity of disease. We screened 187 unrelated male patients for mutations, including 135 with a prior clinical diagnosis of XLRP, 11 with probable XLRP, 30 isolate cases suspected of having XLRP, and 11 with cone-rod degeneration. Mutation screening was performed by single-strand conformation analysis and by ...

      Known for Rpgr Mutations | Retinitis Pigmentosa | Rp2 Exons | Xlinked Humans | Visual Acuity
      KOL-Index: 14666

      OBJECTIVE: To examine if the genes encoding complement factor H (CFH), apolipoprotein E (APOE), and elongation of very-long-chain fatty acids-like 4 (ELOVL4) confer risk of neovascular age-related macular degeneration (AMD) in an independent or interactive manner when controlling for smoking exposure.

      METHODS: We studied 103 unrelated patients with neovascular AMD who each had at least 1 sibling with normal maculae. Smoking histories were obtained. Genotyping was performed by analyzing ...

      Known for Cigarette Smoking | Neovascular Amd | Macular Degeneration | Complement Factor Cfh | Apoe Genotype
      KOL-Index: 14098

      OBJECTIVES: To determine if enhanced s-cone syndrome (ESCS), Goldmann-Favre syndrome (GFS), and clumped pigmentary retinal degeneration (CPRD) are caused by mutations in the NR2E3 gene and to characterize the clinical findings in patients with NR2E3 mutations. Patients One patient with ESCS, one with GFS, and 20 with CPRD.

      METHODS: The coding regions of the NR2E3 and NRL genes and part of the THRB1 coding region were scanned for mutations using single-strand conformation and direct ...

      Known for Patients Nr2e3 Mutations | Retinal Degeneration | Escs Gfs | Nr2e3 Gene | Cone Syndrome
      KOL-Index: 13986

      Unrelated patients with achromatopsia, macular degeneration with onset under age 50 years, cone degeneration or dysfunction, cone-rod degeneration, or macular malfunction were screened for mutations in the three genes known to be associated with achromatopsia: the GNAT2 gene encoding the alpha subunit of cone transducin and the CNGA3 and CNGB3 genes encoding the alpha and beta subunits of the cone cGMP-gated cation channel. We found no examples of patients with GNAT2 mutations. Out of 36 ...

      Known for Macular Degeneration | Patients Achromatopsia | Cngb3 Mutations | Color Vision | Amino Acid
      KOL-Index: 13407

      We used the serial analysis of gene expression (SAGE) technique to catalogue and measure the relative levels of expression of the genes expressed in the human peripheral retina, macula, and retinal pigment epithelium (RPE) from one or both of two humans, aged 88 and 44 years. The cone photoreceptor contribution to all transcription in the retina was found to be similar in the macula versus the retinal periphery, whereas the rod contribution was greater in the periphery versus the macula. ...

      Known for Serial Analysis | Peripheral Retina | Genes Expressed | Pigment Epithelium | Eye Rna
      KOL-Index: 12949

      PURPOSE: To measure the rates of visual acuity, visual field, and ERG loss in patients with X-linked retinitis pigmentosa due to RPGR mutations and to determine whether these rates differ from those of patients with dominant retinitis pigmentosa due to RHO mutations.

      METHODS: Snellen visual acuities, Goldmann visual field areas (V4e white test light), and 30 Hz (cone) full-field ERG amplitudes were recorded for an average of 9.8 years in 113 patients with RPGR mutations. After censoring ...

      Known for Visual Acuity | Retinitis Pigmentosa | Rpgr Mutations | Rho Patients | Legal Blindness
      KOL-Index: 12834

      OBJECTIVE: To examine if the genes encoding the pleckstrin homology domain-containing protein gene (PLEKHA1), hypothetical LOC387715/ARMS2 gene, and HtrA serine peptidase 1 gene (HTRA1) located on the long arm of chromosome 10 (10q26 region) confer risk for neovascular age-related macular degeneration (AMD) in an independent or interactive manner when controlling for complement factor H gene (CFH) genotype and smoking exposure.

      DESIGN: Retrospective matched-pair case-control ...

      Known for Serine Peptidase | Macular Degeneration | Risk Amd | Neovascular Age | 10q26 Region
      KOL-Index: 12294

      Mutations in the genes encoding two proteins of the retinal rod phototransduction cascade, opsin and the beta subunit of rod cGMP phosphodiesterase, cause retinitis pigmentosa (RP) in some families. Here we report defects in a third member of this biochemical pathway in still other patients with this disease. We screened 94 unrelated patients with autosomal dominant RP and 173 unrelated patients with autosomal recessive RP for mutations in the gene encoding the alpha subunit of the rod ...

      Known for Alpha Subunit | Recessive Retinitis | Rod Cgmp | Gated Channel | Mutations Gene
      KOL-Index: 11966

      PURPOSE: To identify pathogenic mutations in the guanylate cyclase-activating protein 1 (GCAP1) and GCAP2 genes and to characterize the biochemical effect of mutation on guanylate cyclase (GC) stimulation.

      METHODS: The GCAP1 and GCAP2 genes were screened by direct sequencing for mutations in 216 patients and 421 patients, respectively, with various hereditary retinal diseases. A mutation in GCAP1 segregating with autosomal dominant cone degeneration was further evaluated biochemically by ...

      Known for Guanylate Cyclase | Dominant Cone | Activating Protein | Gcap1 Mutation | Retinal Degeneration
      KOL-Index: 11951

      BACKGROUND: Bietti crystalline corneoretinal dystrophy (BCD) is an autosomal recessively inherited disorder characterised by tiny yellowish glittering retinal crystals, choroidal sclerosis, and crystals in the peripheral cornea, associated with progressive night blindness. CYP4V2, encoding a member of cytochrome p450 (CYP450) protein family, was recently identified as the causative gene.

      METHODS: We recruited 11 unrelated patients with BCD and characteristic clinical features; eight of ...

      Known for Cyp4v2 Gene | Corneoretinal Dystrophy | Bietti Crystalline | Patients Bcd | Cytochrome P450

      Key People For Retinitis Pigmentosa

      Top KOLs in the world
      #1
      Eliot L Berson
      retinitis pigmentosa visual acuity rhodopsin gene
      #2
      THADDEUS P Dryja
      retinitis pigmentosa rhodopsin gene missense mutation
      #3
      Gerald Allen Fishman
      retinitis pigmentosa visual acuity stargardt disease
      #4
      Michael A Sandberg
      retinitis pigmentosa visual acuity rhodopsin gene
      #5
      John R Heckenlively
      retinitis pigmentosa retinal degeneration visual acuity
      #6
      Samuel G Jacobson
      retinitis pigmentosa leber congenital amaurosis retinal degeneration

      Current affiliation: *TPD Cogan Eye Pathology Laboratory, Massachusetts Eye and Ear, Boston, Massachusetts, United States. | From the David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Bost

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.